Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.02008
European Journal of Endocrinology, Vol 153, Issue 5, 717-718
Copyright © 2005 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohn, A
Right arrow Articles by Chiarelli, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohn, A
Right arrow Articles by Chiarelli, F

LETTER TO THE EDITOR

Increased frequency of subclinical hypothyroidism and thyroid-associated antibodies in siblings of children and adolescents with type 1 diabetes mellitus

A Mohn, S Di Michele, R Faricelli1, S Martinotti1 and F Chiarelli

Department of Paediatrics and 1 Department of Clinical Pathology, University of Chieti, Chieti, Italy

(Correspondence should be addressed to A Mohn; Email: amohn{at}unich.it)

In recent years, it has been well established that early detection of thyroid autoimmunity or disease in children is important, leading to the idea of treating patients with subclinical hypothyroidism in the presence of high serum thyroid antibody, as progression to overt hypothyroidism is common (1). Furthermore, thyroxine replacement therapy started early in patients with subclinical hypothyroidism reduces the risk of hyperlipidemia and atherosclerotic heart disease (2). Disease-associated autoantibodies can be easily used as a tool to identify patients at increased risk of progression to clinical thyroid dysfunction. Because siblings of patients with type 1 diabetes mellitus (T1DM) share the HLA-risk alleles, we asked whether they might be at increased risk of thyroid autoimmunity and disease.

Therefore, screening for thyroid-correlated antibodies, together with thyroid function testing, was offered to siblings of children and adolescents with T1DM. We excluded siblings of diabetic patients with thyroid autoimmunity or disease. As a control group, we also analyzed sera from healthy children and adolescents matched for age and sex without a family history of autoimmune disease. All children were Caucasian from the Abruzzo region of Italy. Written, informed consent was obtained from the parents of all children and adolescents before entry to the study.

A single blood sample was taken for thyroid function testing (thyroid-stimulating hormone (TSH) and free thyroxine (FT4)) and antibodies to thyroglobulin (TG) and to thyroid peroxidase (TPO).

Thyroid hormone levels were determined by double-antibody radioimmunoassay. Normal basal values for our laboratory were 6–18 pg/ml for FT4 and 0.3–4.1 µU/ml for TSH. Antibodies to TG and TPO were quantitated by ELISA. A titer exceeding 100 IU/ml was considered positive. Patients with positive thyroid antibodies were considered to be affected by autoimmune thyroiditis with subclinical hypothyroidism when increased serum TSH (>5 µUI/ml) concentration with normal FT4 values was found.

The screening was performed in 123 siblings (67 M, 56 F) out of 151 (70 M, 81 F) aged 9.2 ± 4.5 years. These children were matched with 140 control subjects (81 M, 59 F) aged 9.2 ± 3.8 years (Table 1Go). The data were evaluated statistically by Fisher’s exact probability test with SPSS, Version 10.0 (SPSS, Chicago, IL, USA).


View this table:
[in this window]
[in a new window]
 
Table 1 Frequency of autoimmune phenomena in siblings of T1DM patients compared to controls without family history of T1DM.
 
Among the group of siblings, nine children (4 M, 5 F) tested positive for antibodies to TG (mean 358 IU/ml, range 108–761) and to TPO (mean 758 IU/ml, range 100–1982). Three of these children presented subclinical hypothyroidism: two adolescent girls (TSH, 9.5 and 7.64 µU/ml; FT, 4.7 and 12 pg/ml respectively) and a 6-year-old boy (TSH, 8.45 µU/ml; FT, 4.8 pg/ml). These three children were started on treatment with L-thyroxine. In the control group, two girls aged 8.8 and 9.8 years respectively presented antibodies to TG (mean 107 IU/ml, range 88–126) and to TPO (mean 181 IU/ml, range 150–202) (P = 0.01) with normal thyroid function.

Despite the relatively small number of subjects, this cross-sectional study highlights that siblings of patients with T1DM present a frequency of 7% of thyroid-associated antibodies, which is significantly higher than in normal controls and is in line with previous studies (35). Furthermore, in our population, we detected an increased frequency of thyroid dysfunction, which is less common, as routine screening for siblings of diabetic patients is usually not performed (6). Although the adolescent girls might have been diagnosed by a thorough clinician, which reflects the occurrence within the general population, the boy was at high risk of remaining undetected for a long time. This small study demonstrates that clinicians should be highly aware of the possibility of thyroid dysfunction in this population, and early diagnostic procedures should be performed, especially in consideration of the well-documented long-term complications of undiagnosed hypothyroidism.

References

    1. Pearce EN, Farwell AP & Braverman LE. Thyroiditis. New England Journal of Medicine 2003 348 2646–2655.[Free Full Text]

    2. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E & Monzani F. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. Journal of Clinical Endocrinology and Metabolism 2003 88 3731–3737.[Abstract/Free Full Text]

    3. Hanukoglu A, Mizrachi A, Dalal I, Admoni O, Rakover Y, Bistritzer Z, Levine A, Somekh E, Lehmann D, Tuval M, Boaz M & Golander A. Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care 2003 26 1235–1240.[Abstract/Free Full Text]

    4. Jaeger C, Hatziagelaki E, Petzoldt R & Bretzel RG. Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects. Diabetes Care 2001 24 27–32.[Abstract/Free Full Text]

    5. Hansen D, Bennedbaek FN, Hoier-Madsen M, Hegedus L & Jacobsen BB. A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. European Journal of Endocrinology 2003 148 245–251.[Abstract]

    6. Betterle C, Zanette F, Pedini B, Presotto F, Rapp LB, Monciotti CM & Rigon F. Clinical and subclinical organ-specific autoimmune manifestations in type-1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 1984 26 431–436.[Medline]


Received 18 July 2005
Accepted 25 July 2005





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohn, A
Right arrow Articles by Chiarelli, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohn, A
Right arrow Articles by Chiarelli, F


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS